News Updates

GSK, Moderna and CSL Seqirus are developing or testing human vaccines against the highly pathogenic subtype of avian influenza that has killed a record number of birds in an ongoing outbreak, and Sanofi says it is ready to begin production of a vaccine. Most wealthy countries have long-standing contracts that would claim most vaccine doses in the event of a human bird flu outbreak, while the World Health Organization has signed contracts with 14 manufacturers for 10% of their vaccines straight off the production line in the event of a flu pandemic. Reuters (3/20)